Women

  • Just under 2,000 women are waiting to see a gynaecologist at University Hospital Galway at present.

    There are more than 28,000 women nationally waiting for such appointments, with 5,000 waiting for more than a year.

    The Irish Hospital Consultants Association says the consultant recruitment and retention crisis is a major cause of the delays.

    Gynaecologist Dr. Nóirín Russell says women will have delayed cancer diagnoses as a result.

  • A callout is going out to women today, to join Bus Eireann as bus drivers.

    The company's holding open days at its depots in Cork, Galway and Dublin during the day.

    It's also recruiting Apprentice Heavy Vehicle Mechanics this year and is encouraging applications from women.

     

  • More than 75% of the woman affected by the CervicalCheck controversy are now cancer free.

    According to HSE data, at least 165 of the 221 women diagnosed at stage two or earlier, now have no evidence of the active disease.

    However 21 of the 221 women have died, and 14 are still undergoing treatment, and their prognosis has not been shared.

    The figures also show a small number of women did not actually have cervical cancer at all.

  •  

    Some women may have waited almost a year now for a result from their cervical check screening.

    That's according to Fianna Fáil's health spokesman, Stephen Donnelly.

    The HSE says 800 women haven't received the test-results because of an IT problem at a US lab.

    It mainly involves women who were sent for rechecks between last October and June 25th of this year.

    The HSE has apologised, but Deputy Donnelly says that's not good enough.

     

  • Women suffering with cervical cancer are to be offered the drug Pembro for their treatment after a high profile campaign.

    It had only been available to the victims of the cervical check scandal until now.

    Doctors will be able to offer it on a case by case basis if they deem it could help the woman.

    The cost will be footed by the state and it will only be available to cervical cancer sufferers.